DNA
Price:
$9.4
Market Cap:
$540.30M
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2021-04-19
Stock Exchange
NYSE
Ticker
DNA
According to Ginkgo Bioworks Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -70.11%. This represents a change of 305.01% compared to the average of -17.31% of the last 4 quarters.
The mean historical ROE of Ginkgo Bioworks Holdings, Inc. over the last ten years is -62.64%. The current -70.11% ROE has changed 11.92% with respect to the historical average. Over the past ten years (40 quarters), DNA's ROE was at its highest in in the March 2001 quarter at 0%. The ROE was at its lowest in in the December 2021 quarter at -106.33%.
Average
-62.64%
Median
-54.41%
Minimum
-121.57%
Maximum
0%
Discovering the peaks and valleys of Ginkgo Bioworks Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 343.01%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -121.57%
Year | ROE | Change |
---|---|---|
2023 | -81.38% | -32.87% |
2022 | -121.23% | -0.28% |
2021 | -121.57% | 343.01% |
2020 | -27.44% | 13.39% |
2019 | -24.20% | -Infinity% |
The current ROE of Ginkgo Bioworks Holdings, Inc. (DNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-108.06%
5-year avg
-75.16%
10-year avg
-62.64%
Ginkgo Bioworks Holdings, Inc.’s ROE is less than Ocean Biomedical, Inc. (75.64%), greater than Enveric Biosciences, Inc. (-201.01%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), greater than Elevation Oncology, Inc. (-59.73%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-58.44%),
Company | ROE | Market cap |
---|---|---|
75.64% | $20.82M | |
-201.01% | $3.25M | |
-505.74% | $3.38M | |
-59.73% | $33.35M | |
29.68% | $5.24M | |
-58.44% | $1.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ginkgo Bioworks Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ginkgo Bioworks Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ginkgo Bioworks Holdings, Inc.'s ROE?
How is the ROE calculated for Ginkgo Bioworks Holdings, Inc. (DNA)?
What is the highest ROE for Ginkgo Bioworks Holdings, Inc. (DNA)?
What is the 3-year average ROE for Ginkgo Bioworks Holdings, Inc. (DNA)?
What is the 5-year average ROE for Ginkgo Bioworks Holdings, Inc. (DNA)?
How does the current ROE for Ginkgo Bioworks Holdings, Inc. (DNA) compare to its historical average?